+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Glycomics/Glycobiology Market Size, Share & Trends Analysis Report By Application (Drug Discovery & Development, Diagnostics), By Product (Instruments, Enzymes), By End Use, By Region, And Segment Forecasts, 2019 - 2026

  • ID: 4621738
  • Report
  • 137 pages
  • Grand View Research
1 of 3

FEATURED COMPANIES

  • Agilent Technologies
  • Bruker
  • Danaher
  • Merck KGaA
  • New England Biolabs
  • ProZyme
  • MORE
The global glycomics/glycobiology market size is expected to reach USD 2.4 billion by 2026 registering a CAGR of 14.7%, according to this report. Rising focus on glycomics and proteomics research has led to the growth of this market. Significant investments in this field have also enabled academic researchers to develop new tools. Thus, the field of glycoscience is growing, which is a high impact rendering driver for the market. Glycans are essential in biological processes and research on them helps in understanding the biology more comprehensively, without specializing in glycobiology. According to 2018 BDO Biotech Briefing, the average R&D expenditure of the mid-sized biotech companies increased around 14% from 2016 to 2017.

Growing drug discovery and development is leading to a rise in R&D investments by biotech companies. Thus, the need for glycomics research techniques for conducting comprehensive glycomes study is constantly increasing. Rise in the number of initiatives being undertaken by the government to increase funding for R&D has led to the increased need for glycomics techniques. The Australian government invested around USD 10.4 billion for scientific research activities and innovations for the period 2017-2018. The Irish Government also announced a USD 5.6 billion spending program in 2015, which was aimed at increasing the number of scientific research activities from 25,000 to 40,000.

Such funding initiatives are expected to boost the demand for glycomics research techniques in near future. Key companies are also undertaking extensive R&D initiatives to develop new and technologically advanced products. For instance, in 2018, Shimadzu Corp. collaborated with PREMIER Biosoft, a global company in the field of bioinformatics solutions, with an aim to introduce its LCMS-9030 Quadrupole Time of Flight (Q-TOF) mass spectrometry system for advance glycomics and lipidomics data research analysis. In addition, in 2016, ProZyme, Inc. launched Gly-Q Glycan Analysis System, an integrated platform that enables user-friendly and high-throughput glycoanalysis.

Further key findings from the study suggest:
  • Enzymes is expected to be the fastest-growing segment in the global glycobiology market due to its wide application scope in research & diagnostics and repetitive purchase of these products
  • In the application segment, drug discovery & development accounted for the largest revenue share in 2018 owing to high demand for personalized medicines and focus on novel drug development
  • North America led the global glycomics/glycobiology market in 2018 and is expected to continue its dominance during the forecast period
  • Presence of a large number of research laboratories and pharmaceutical and biotechnology companies in North America is the major factor driving the regional market
  • Europe is expected to register the highest CAGR from 2019 to 2026 due to rising number of pharmaceutical and biopharmaceutical companies in the region
  • Some of the key companies include Danaher, ProZyme, Shimadzu Corporation, Agilent Technologies, Bruker, Merck KGaA, Takara Bio, Inc., New England Biolabs, ThermoFisher Scientific, Inc., and Waters Corporation

Please note: This product will be delivered within 48 business hours after receipt of order.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Agilent Technologies
  • Bruker
  • Danaher
  • Merck KGaA
  • New England Biolabs
  • ProZyme
  • MORE
Chapter 1 Methodology and Scope
1.1 Market segmentation & scope
1.2 Market definition
1.3 Information procurement
1.4 Purchased database
1.5 Internal database
1.6 Secondary sources & third party perspectives
1.7 Primary research
1.8 Information analysis
1.9 Data analysis models
1.10 Market formulation & data visualization
1.11 Data validation & publishing

Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights

Chapter 3 Glycomics Market Variables, Trends & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration and Growth Prospect Mapping
3.3 Product Pipeline Analysis, by Stage
3.4 Industry Value Chain Analysis
3.4.1 Cost structure analysis
3.4.2 User perspective analysis
3.4.2.1 Consumer behavior analysis
3.4.2.2 Market influencer analysis
3.4.3 Cost analysis breakdown
3.4.4 List of key end users, by region
3.5 Technology Overview
3.5.1 Technology timeline
3.6 Regulatory Framework
3.6.1 Reimbursement framework
3.6.2 Standards and compliances
3.7 Market Dynamics
3.7.1 Market driver analysis
3.7.1.1 Increasing focus on glycomics and proteomics research
3.7.1.2 Increasing investment in R&D by research institutes and pharmaceutical & biotechnology companies
3.7.1.3 Technological advancements in glycomics instruments
3.7.2 Market Restraint Analysis
3.7.2.1 Stringent government policies and regulations
3.7.2.2 High cost of glycomics instruments
3.7.3 Industry challenges
3.7.3.1 Presence of ambiguous regulatory framework
3.8 Glycomics Market Analysis Tools
3.8.1 Industry analysis - Porter’s
3.8.1.1 Supplier Power
3.8.1.2 Buyer Power
3.8.1.3 Substitution Threat
3.8.1.4 Threat from new entrants
3.8.1.5 Competitive Rivalry
3.8.2 pestle Analysis
3.8.2.1 Political Landscape
3.8.2.2 Environmental Landscape
3.8.2.3 Social landscape
3.8.2.4 Technology landscape
3.8.2.5 Legal Landscape
3.8.3 Major deals and strategic alliances analysis
3.8.3.1 Joint ventures
3.8.3.2 Mergers and acquisitions
3.8.3.3 Licensing and partnership
3.8.3.4 Technology collaborations
3.8.3.5 Strategic Divestments
3.8.4 Market entry strategies
3.8.5 Case Studies

Chapter 4 Glycomics Market - Competitive Analysis
4.1 Recent Developments & Impact Analysis, by Key Market Participants
4.2 Company Categorization
4.3 Vendor Landscape
4.3.1 List of key distributors and channel partners
4.3.2 Key customers
4.3.3 Key company market share analysis, 2018
4.4 Public Companies
4.4.1 Company market position analysis
4.4.2 Company market share, by region
4.4.3 Competitive dashboard analysis
4.4.3.1 Market differentiators
4.4.3.2 Synergy analysis: Major deals and strategic alliances
4.5 Private Companies
4.5.1 List of key emerging companies
4.5.2 Regional network map
4.5.3 Company market position analysis
4.5.4 Supplier ranking

Chapter 5 Glycomics Market: Product Estimates And Trend Analysis
5.1 Definition & Scope
5.2 Product Market Share Analysis, 2018 & 2026
5.3 Segment Dashboard
5.4 Global Glycomics Market, by Product, 2015 to 2026
5.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
5.5.1 Enzymes
5.5.1.1 Enzymes market, 2015 to 2026 (USD Million)
5.5.1.2 Glycosidases
5.5.1.2.1 Glycosidases market, 2015 to 2026 (USD Million)
5.5.1.3 Neuraminidases
5.5.1.3.1 Neuraminidases market, 2015 to 2026 (USD Million)
5.5.1.4 Glycosyltransferases
5.5.1.4.1 Glycosyltransferases market, 2015 to 2026 (USD Million)
5.5.1.5 Sialyltransferases
5.5.1.5.1 Sialyltransferases market, 2015 to 2026 (USD Million)
5.5.1.6 Others
5.5.1.6.1 Others market, 2015 to 2026 (USD Million)
5.5.2 Kits
5.5.2.1 Kits market, 2015 to 2026 (USD Million)
5.5.2.2 Glycan labelling kits
5.5.2.2.1 Glycan labelling kits market, 2015 to 2026 (USD Million)
5.5.2.3 Glycan purification kits
5.5.2.3.1 Glycan purification kits market, 2015 to 2026 (USD Million)
5.5.2.4 Glycan release kits
5.5.2.4.1 Glycan release kits market, 2015 to 2026 (USD Million)
5.5.2.5 Other glycomics kits
5.5.2.5.1 Other glycomics kits market, 2015 to 2026 (USD Million)
5.5.3 Reagents
5.5.3.1 Reagents market, 2015 to 2026 (USD Million)
5.5.3.2 Glycoproteins
5.5.3.2.1 Glycoproteins market, 2015 to 2026 (USD Million)
5.5.3.3 Monosaccharides
5.5.3.3.1 Monosaccharides market, 2015 to 2026 (USD Million)
5.5.3.4 Oligosaccharides
5.5.3.4.1 Oligosaccharides market, 2015 to 2026 (USD Million)
5.5.3.5 Others
5.5.3.5.1 Others market, 2015 to 2026 (USD Million)
5.5.4 Instruments
5.5.4.1 Instruments Market, 2015 to 2026 (USD Million)
5.5.4.2 Mass spectrometers
5.5.4.2.1 Mass spectrometers market, 2015 to 2026 (USD Million)
5.5.4.3 HPLC
5.5.4.3.1 HPLC market, 2015 to 2026 (USD Million)
5.5.4.4 MALDI-TOF
5.5.4.4.1 MALDI-TOF market, 2015 to 2026 (USD Million)
5.5.4.5 Array systems
5.5.4.5.1 Array systems market, 2015 to 2026 (USD Million)
5.5.4.5 Other instruments
5.5.4.5.1 Other instruments market, 2015 to 2026 (USD Million)

Chapter 6 Glycomics Market: Application Estimates And Trend Analysis
6.1 Definition & Scope
6.2 Application Market Share Analysis, 2018 & 2026
6.3 Segment Dashboard
6.4 Global Glycomics Market, by Application, 2015 to 2026
6.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
6.5.1 Drug discovery & development
6.5.1.1 Drug discovery & development market, 2015 to 2026 (USD Million)
6.5.1.2 Drug discovery & development market, by product, 2015 to 2026 (USD Million)
6.5.2 Diagnostics
6.5.2.1 Diagnostics market, 2015 to 2026 (USD Million)
6.5.2.2 Diagnostics market, by product, 2015 to 2026 (USD Million)
6.5.3 Other applications
6.5.3.1 Other applications market, 2015 to 2026 (USD Million)
6.5.3.2 Other applications market, by product, 2015 to 2026 (USD Million)

Chapter 7 Glycomics Market: End-use Estimates And Trend Analysis
7.1 Definition & Scope
7.2 End-use Market Share Analysis, 2018 & 2026
7.3 Segment Dashboard
7.4 Global Glycomics Market, by End-use, 2015 to 2026
7.5 Market Size & Forecasts and Trend Analyses, 2015 to 2026
7.5.1 Academic & Research Institutes
7.5.1.1 Academic and research institutes market, 2015 to 2026 (USD Million)
7.5.2 Pharmaceutical & Biotechnology Companies
7.5.2.1 Pharmaceutical & biotechnology companies market, 2015 to 2026 (USD Million)
7.5.3 Contract Research Organizations (CROs)
7.5.3.1 CROs market, 2015 to 2026 (USD Million)

Chapter 8 Glycomics Market: Regional Estimates & Trend Analysis
8.1 Regional Market Snapshot
8.2 Regional Market Share and Leading Players, 2018
8.2.1 North America
8.2.2 Europe
8.2.3 Latin America
8.2.4 Asia Pacific
8.2.5 Middle East & Africa
8.3 Market Share Analysis by Country, 2018
8.3.1 North America
8.3.1.1 U.S.
8.3.1.2 Canada
8.3.2 Europe
8.3.2.1 U.K.
8.3.2.2 Germany
8.3.2.3 Spain
8.3.2.4 France
8.3.2.5 Italy
8.3.2.6 Russia
8.3.3 Latin America
8.3.3.1 Brazil
8.3.3.2 Mexico
8.3.3.3 Argentina
8.3.4 Asia Pacific
8.3.4.1 Japan
8.3.4.2 China
8.3.4.3 India
8.3.4.4 South Korea
8.3.4.5 Singapore
8.3.4.6 Australia
8.3.5 Middle East & Africa
8.3.5.1 South Africa
8.3.5.2 Saudi Arabia
8.3.5.3 UAE
8.4 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
8.4.1 North America
8.4.2 Europe
8.4.3 Latin America
8.4.4 Asia Pacific
8.4.5 Middle East & Africa
8.5 Market Size & Forecasts, and Trend Analysis, 2018 to 2026
8.5.1 North America
8.5.1.1 U.S.
8.5.1.1.1 U.S. Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.1.2 Canada
8.5.1.2.1 Canada Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.2 Europe
8.5.2.1 U.K.
8.5.2.1.1 U.K. Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.2.2 Germany
8.5.2.2.1 Germany Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.2.3 Spain
8.5.2.3.1 Spain Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.2.4 France
8.5.2.4.1 France Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.2.5 Italy
8.5.2.5.1 Italy Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.2.6 Russia
8.5.2.6.1 Russia Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.3 Latin America
8.5.3.1 Brazil
8.5.3.1.1 Brazil Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.3.2 Mexico
8.5.3.2.1 Mexico Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.3.3 Argentina
8.5.3.3.1 Argentina Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.4 Asia Pacific
8.5.4.1 Japan
8.5.4.1.1 Japan Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.4.2 China
8.5.4.2.1 China Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.4.3 India
8.5.4.3.1 India Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.4.4 South Korea
8.5.4.4.1 South Korea Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.4.5 Singapore
8.5.4.5.1 Singapore Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.4.6 Australia
8.5.4.6.1 Australia Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.5 Middle East & Africa
8.5.5.1 South Africa
8.5.5.1.1 South Africa Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.5.2 Saudi Arabia
8.5.5.2.1 Saudi Arabia Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)
8.5.5.3 UAE
8.5.5.3.1 UAE Market Size & Forecasts And Trend Analysis, 2015 to 2026 (USD Million)

Chapter 9 COMPANY PROFILE
9.1 Company Profiles
9.1.1 Thermo Fisher Scientific, Inc.
9.1.1.1 Company overview
9.1.1.2 Financial Performance
9.1.1.3 Product benchmarking
9.1.1.4 Strategic initiatives
9.1.2 Merck KGaA
9.1.2.1 Company overview
9.1.2.2 Financial Performance
9.1.2.3 Product benchmarking
9.1.2.4 Strategic initiatives
9.1.3 Agilent Technologies
9.1.3.1 Company overview
9.1.3.2 Financial Performance
9.1.3.3 Product benchmarking
9.1.3.4 Strategic initiatives
9.1.4 Bruker
9.1.4.1 Company overview
9.1.4.2 Financial Performance
9.1.4.3 Product benchmarking
9.1.4.4 Strategic initiatives
9.1.5 New England Biolabs
9.1.5.1 Company overview
9.1.5.2 Financial Performance
9.1.5.3 Product benchmarking
9.1.5.4 Strategic initiatives
9.1.6 Danaher
9.1.6.1 Company overview
9.1.6.2 Financial Performance
9.1.6.3 Product benchmarking
9.1.6.4 Strategic initiatives
9.1.7 Shimadzu Corporation
9.1.7.1 Company overview
9.1.7.2 Financial Performance
9.1.7.3 Product benchmarking
9.1.7.4 Strategic initiatives
9.1.8 Takara Bio, Inc.
9.1.8.1 Company overview
9.1.8.2 Financial Performance
9.1.8.3 Product benchmarking
9.1.8.4 Strategic initiatives
9.1.8 Waters Corporation
9.1.8.1 Company overview
9.1.8.2 Financial Performance
9.1.8.3 Product benchmarking
9.1.8.4 Strategic initiatives
9.1.9 ProZyme
9.1.9.1 Company overview
9.1.9.2 Financial Performance
9.1.9.3 Product benchmarking
9.1.9.4 Strategic initiatives
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Agilent Technologies
  • Bruker
  • New England Biolabs
  • Danaher
  • Shimadzu Corporation
  • Takara Bio, Inc.
  • Waters Corporation
  • ProZyme
Note: Product cover images may vary from those shown
Adroll
adroll